Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AGN - UroGen Is A Compelling Value With Recent FDA Approval


AGN - UroGen Is A Compelling Value With Recent FDA Approval

Urogen Pharma Ltd. (URGN) is now a commercial biotechnology company that designs and develops therapies for urological pathologies. It was founded in 2004, and while technically incorporated in Israel, URGN's corporate offices are located in Princeton, New Jersey. The company had 173 employees as of 2/17/2020, of which 127 were in the United States and 46 work out of Israel.

URGN's primary technology is called RTGel, which is a drug delivery system. RTGel allows a medicine (URGN's two flagship products use mitimycin) to be delivered in a liquid form that then turns into

Read more ...

Stock Information

Company Name: Allergan plc
Stock Symbol: AGN
Market: NYSE
Website: allergan.com

Menu

AGN AGN Quote AGN Short AGN News AGN Articles AGN Message Board
Get AGN Alerts

News, Short Squeeze, Breakout and More Instantly...